Appointment of the former Head of Israel’s National Security Council and Former Acting National Security Advisor to Prime Minister Benjamin Netanyahu marks another step in laying the scientific and strategic foundation for SciSparc’s planned entry into the Agentic AI sector
TEL AVIV, Israel, Nov. 16, 2026 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced the appointment of Prof. Jacob Nagel, a renowned technology and national security expert with extensive experience in artificial intelligence (“AI”), advanced technologies and cybersecurity, to the Company’s Scientific Advisory Board for AI and Cybersecurity.
The appointment marks another step in SciSparc’s efforts to establish the scientific and strategic foundation for its planned entry into the evolving Agentic AI sector. Following the Company’s previously announced decision to explore opportunities in the field, SciSparc is moving to put its plans into action by building a network of renowned scientific and technology experts to support its evaluation of potential technologies, strategic partnerships and opportunities.
Prof. Nagel brings decades of experience at the intersection of advanced technology, AI, cybersecurity, defense innovation and strategic decision-making.
Prof. Nagel is a Visiting Professor at the Technion- Israel Institute of Technology (“Technion”) and heads the Technion’s Center for Security Science and Technology. He previously served as the Head of Israel’s National Security Council and Former Acting National Security Advisor to Prime Minister Benjamin Netanyahu from 2016 to 2017. Prior to that, he held senior positions within Israel’s Ministry of Defense, including serving as Scientific Deputy and Acting Head of the military research and development directorate. He also spent 16 years as a technical expert in Israel’s national signals intelligence unit (8200).
In 2025, Prof. Nagel chaired Israel’s National Committee for Accelerating the Field of Artificial Intelligence, which developed recommendations aimed at strengthening Israel’s position in the global AI landscape, including in areas such as AI infrastructure, computing capabilities, research, human capital and national AI strategy.
His broad experience across AI, emerging technologies, cybersecurity and national-level technology strategy is expected to provide SciSparc with valuable perspective as the Company evaluates the developing Agentic AI ecosystem and considers potential opportunities for entry into the sector.
The appointment follows SciSparc’s recent addition of Prof. Carmel Domshlak, an internationally recognized AI expert and professor at the Technion, to the Company’s Scientific Advisory Board. Prof. Domshlak brings extensive expertise in intelligent autonomous behavior, automated reasoning, action planning, sequential decision-making and multi-agent systems.
About SciSparc Ltd. (Nasdaq: SPRC):
SciSparc Ltd. is undergoing a strategic transformation toward Agentic AI-powered technologies, with a focus on applications in cybersecurity and finance. Building on its decision to target the Agentic AI market and the establishment of a Scientific Advisory Board for AI and cybersecurity, the Company is evaluating technologies, companies and business opportunities across the Agentic AI ecosystem. Agentic AI refers to artificial intelligence systems designed to autonomously plan and execute tasks to achieve defined objectives.
In parallel, through its subsidiary NeuroThera Labs Inc. (“NeuroThera”), SciSparc continues to advance its clinical-stage cannabinoid pharmaceutical programs, including SCI-110 for Tourette syndrome and Alzheimer’s disease-related agitation, and SCI-210 for autism spectrum disorder and status epilepticus. NeuroThera also holds a controlling interest in a subsidiary that sells hemp seed oil-based products on Amazon.com.
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. For example, SciSparc uses forward-looking statements when it discusses its rapid move to put its plans into action by building a leading network of scientific and technology expertise to support its evaluation of potential technologies, strategic partnerships and opportunities and its evaluation of the developing Agentic AI ecosystem and potential opportunities for entry into the sector. Because such statements deal with future events and are based on SciSparc’s current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of SciSparc could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in SciSparc’s Annual Report on Form 20-F, filed with the SEC on April 29, 2026, as amended, and in subsequent filings with the U.S. Securities and Exchange Commission. Except as otherwise required by law, SciSparc disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events or circumstances or otherwise.
Investor Contact:
[email protected]
Tel: +972-3-6167055
